that it is similar to that seen in healthy volunteers is not based on solid data. Only a few articles have included a small group of asymptomatic BMT patients as a comparaThe purpose of this study was to assess the cytological composition of bronchoalveolar lavage (BAL) fluid in tive or control group. [1] [2] [3] [4] [5] [6] Observations in healthy individuals have contributed to define the inflammatory and immune allogeneic BMT patients without lung complications and compare it with that obtained from healthy volunteers.
The healthy volunteer group comprised 25 individuals We defined neutrophilic alveolitis as the presence of Ͼ5% neutrophils, and lymphocytic alveolitis as у22% who were included according to the following criteria: absence of respiratory symptoms, occupational history, lymphocytes in the BAL. A differential cell count of the return from an average lavage from a normal adult reveals: medication, exposure to domestic animals or respiratory infections during the 6 weeks prior to BAL. Sixteen of 93 Ϯ 5% macrophages; 7 Ϯ 1% lymphocytes; and Ͻ1% neutrophils, eosinophils or basophils. 7 The percentage of these volunteers had been used as the control group in a previously published study. 10 neutrophils is consistently low [11] [12] [13] while the lymphocyte percentage shows a wider variation. The upper normal lymphocyte percentage in lavage fluid is considered to be in Bronchoalveolar lavage the 10-14% range, although it falls below 10% in most individuals. 7, 13 Based on these data we chose clearly abnorAll bronchoscopies were performed through a fibreoptic bronchoscope (Olympus BF-B3R, Hamburg, Germany or mal values to define both neutrophilic and lymphocytic alveolitis. Pentax BF-18X, Langley, UK), by or under the direct supervision of one of the authors (RG, JA, JAN) in the morning after an overnight fast. Atropine was used as premedication in some patients. Local anaesthesia of the pharTotal cell counts yngeal and hypopharyngeal areas was achieved with an aerosol spray of 1% lydocaine which was administered into the tracheobronchial tree at a maximum dose of 8 ml. SupThe pooled lavage fluid was centrifuged at 300 g for 10 min. The cell pellet was resuspended in 1-5 ml of RPMIplemental oxygen was given transnasally at a flow of 4 l/min only when oxygen saturations fell below 90%. After 1640 solution and counted on a Neubauer haemocytometer (Brand, Germany). Results were reported as number of inspection of the bronchial segments, the tip of the bronchoscope was wedged into one of the subsegments of the cells per milliliter of returned BAL. In our study, the total cell count from 16 of 25 healthy volunteers was disregarded right middle lobe for lavage. Three or five aliquots were used in the BMT patients, and five or six in the healthy since a different technique was used (the count was carried out directly on the original uncentrifuged pooled BAL volunteer group. Fifty millilitre aliquots of room temperature isotonic saline solution were instilled as bolus through liquid and counted on an automated counter). 10 We used an haemocytometer instead of an automated method as it the bronchoscope with a syringe. Then, immediately after the instillation, each aliquot was suctioned back gently by has been shown that automated methods frequently underestimate the number of cells recovered by lavage. Macrohand. The first aliquot recovered was discarded to lessen the possibility of bronchial contamination but it was quantphage size may be outside the window setting used. 14, 15 ified to measure the total volume recovered. The rest of the aliquots were strained through sterile gauze and pooled into sterile plastic cup. The well mixed pooled BAL was divided Patient characteristics and transplant events into three portions: 30-40 ml were used to perform microbiologic studies; 10-15 ml were sent to the Pathology laboratory for differential cell count while the rest of the Patient characteristics studied were age, gender and smoking history. Transplant events taken into account were total fluid was processed for total cell count.
Each BAL was examined for the presence of bacteria, body irradiation (TBI) in the conditioning regimen vs non-TBI regimens; high-dose prophylactic acyclovir; corticofungi and viruses. All BAL cultures were negative for mycobacteria although CMV was isolated in 16 BALs. steroid therapy before BAL; acute GVHD before or at BAL; day of leucocyte engraftment; peripheral white cell Bacterial growth у10 4 colonies/ml (two Pseudomonas aeruginosa and one E. coli) was found in three BALs. All differential count taken at the time of bronchoscopy; and CMV isolation from the BAL. patients with a positive bacterial growth were asymptomatic and none received antimicrobial therapy for these isolations. Finally, the patients with CMV isolation were also asymptomatic and none developed pneumonitis.
Statistical analysis
Evaluation of BAL cell composition Baseline characteristics (age and sex) of both the transplant and healthy volunteer groups were compared using the All differential cell counts were performed by the same pathologist who was unaware of the patient's condition.
Mann-Whitney and 2 tests. The association between BAL differential count and other variables was studied by KrusCytocentrifuged preparations were made using a Cytospin 3 cytocentrifuge (Shandon Southern Instruments, Runcorn, kal-Wallis, Mann-Whitney or simple regression analysis (Spearman correction coefficient was used). A significance UK) by placing an aliquot (0.5 ml) of the original mixed pooled BAL fluid (centrifuged at 1200 r.p.m. for 5 min) on level of 0.05 was used for all the analyses. In patients with more than one BAL, the relation between the first and the to a glass slide using filter paper and stained with MayGrünwald-Giemsa. Differential cell counts, expressed as second differential cellular BAL compositions (neutrophils, lymphocytes and macrophages) was analysed by the Wilpercentages, were performed by analysing May-Grünwald-Giemsa-stained smears and counting 400 cells using the coxon matched-pairs signed-ranks test. All P values are two sided. random field counting technique. BALs (4/6). Eighty-two percent (46/56) of the patients had were done after leucocyte engraftment except in three one or more BALs showing neutrophil alveolitis. The three cases. BALs were divided into three groups according to BALs performed before the patient showed leucocyte the post-BMT day when bronchoscopy was performed: (1) engraftment had a normal neutrophil percentage. Lymphobefore day +50 (34 BALs); (2) between days +50 and +100 cytic alveolitis was detected in 20.4% of all BALs (20/98), (39 BALs); (3) after day +100 (25 BALs). The percentage 13.5% of first BALs (7/52), 25% of second BALs (10/40) of volume recovered was lower in the BMT patient group and in 50% of third BALs (3/6). Thirty percent (17/56) of than in the healthy volunteer group: 60% (38-81.6) vs the patients had one or more BALs with lymphocytic 78.8% (63-91.3), respectively (median range) (P = 0.0001).
alveolitis. The control group consisted of BALs from 18 healthy No significant differences were seen in BAL cellular volunteers (Table 1) . Sixteen of these volunteers had parcomposition with regard to acute GVHD, TBI vs non-TBI ticipated in a previously published study. 10 regimens, smoking history, use of high-dose acyclovir, perThe BAL cellular composition of BMT patients was ipheral white cell differential count taken at the time of clearly different from that of healthy volunteers (Table 2) .
BAL, and time of BAL (Ͻ day +50; days +50 to +100; BMT patients had a significantly greater percentage of neuand Ͼ +100) ( Table 3 ). In patients with two BALs no diftrophils and lymphocytes, a lower percentage of macroferences were found between the first and the second. We phages and similar numbers of eosinophils as compared to observed only a weak correlation between the day of healthy volunteers. There was also a higher degree of variengraftment and BAL cellular composition: the later the engraftment occurred the more lymphocytes (r 2 = 0.066; P was not statistically significant. Therefore, neutrophilic
alveolitis is a common finding in post-BMT asymptomatic
Data are median (range).
patients not explained by the presence of asymptomatic CMV infection in most cases. It is interesting to note that of cells in the BAL fluid was studied in 44 BALs (25 first BALs; 18 second BALs; one third BAL) corresponding to only three of 15 patients with a CMV-positive BAL had a normal percentage of BAL neutrophils, and that one of 27 consecutive BMT patients (24 of which were not included in the BAL differential cell count study) and was these three cases was a patient without leucocyte engraftment. As already shown, all patients without leucocompared with that observed in seven healthy volunteers. All patients received cyclosporine plus a short course of cyte engraftment had a normal neutrophil percentage in BAL. Therefore, 12 of 14 patients with leucocyte methotrexate as GVHD prophylaxis. Seventeen BALs were performed before day +50 post-BMT, 15 between day +50 engraftment and a CMV-positive BAL had an alveolar neutrophilia (7-30%).
and +100, and 12 BALs after +100 days post-transplant. The total lavage cell counts of BMT patients (median Clinical records were reviewed for the existence of respiratory symptoms from 2 weeks before up to 2 weeks after 8.44 × 10 4 /ml, range 1.0-27.8) were not different from those of the healthy controls (median 9.3 × 10 4 /ml, range bronchoscopy. During this period, nine patients had respiratory symptoms (a combination of rhinorrhea, pharyngeal 7.4-9.8) (P = 0.38). However, since the number of control BALs was low these results must be interpreted with caudiscomfort, cough, conjunctivitis, fever) suggestive of an upper tract involvement. None developed a lung infiltrate, tion. No differences in BAL cellularity were noted in BMT patients between the first and second BAL; the three time and all symptoms receded without antibiotic treatment except in three cases treated with oral amoxicilin/clavulanic periods of BAL examination (Ͻ50 day; 50-100 days; Ͼ100 day post-transplant); and the use of TBI vs chemotherapy acid. The percentage of neutrophils (median 7%; range 0-32.5) and lymphocytes (median 9.25%; range 0-77) of the in the conditioning regimen. There was a significant difference in BAL cellularity with respect to the patients' smokpatients without upper respiratory symptoms were the same as for the whole population. Thus, mild upper respiratory ing history: smokers had more cells (median 12.3 × 10 4 /ml, range 3.2-27.9) than non-smokers (median 6.7 × 10 4 /ml, tract infections were not the cause of the alveolar neutrophilia/lymphocytosis seen in this BMT patient popurange 1.0-13.9) (P = 0.0027). lation.
Discussion

Total lavage cell counts
Characteristics of the patients and healthy volunteers with
This study describes the 'normal' differential and total cell counts in the BAL from BMT patients without evidence of total lavage cell counts are shown in Table 4 . The number Table 4 Characteristics of patients and healthy volunteers with BAL total cell counts lung disease. Our data show that the BAL cellular compoThe subject is a smoker. The finding of similar percentages of BAL neutrophils in both smokers and non-smokers sition during the first 6 months post-transplant is clearly different from that in healthy volunteers: transplant patient argues against this possibility. (3) The subject has a chronic lung or inflammatory airway disease associated with an BALs yielded many more neutrophils (which was the most impressive finding), more lymphocytes, fewer macrophages accumulation of neutrophils in the alveolar structure. None of our patients had clinical symptoms of lung disease at the and a similar low percentage of eosinophils as compared with a group of healthy volunteers. BMT patients also time of BAL. The possible existence of a few cases with a subclinical lung disease that could have led to a pathologishowed a greater dispersion in the percentage of cellular populations. These cellular variations were seen early durcal increase in alveolar neutrophils does not explain the 82% of neutrophilic alveolitis seen in the whole population. ing the first month after BMT and did not show a significant change over the first 6 months studied. When a sequential It does not seem likely that such a high percentage of patients had a subclinical alveolitis-producing lung disease. BAL was performed a striking number of our asymptomatic patients (84%) had alveolitis: neutrophilic (Ͼ5% neutro-A counting error cannot explain the increased incidence of neutrophilic alveolitis, as neutrophils are easily recognised phils in BAL) in 82% and lymphocytic (у22% lymphocytes in BAL) in 30%. Therefore, the BAL composition and misidentification is not a problem with this type of cell. Drug-induced alveolitis could be another possible explaafter an allogeneic BMT is clearly abnormal and different from that of healthy volunteers, even in patients without nation for the abnormal BAL cellular composition seen in our patients. BMT patients receive a great number of drugs, clinically evident lung complications and with a bronchoscopy scheduled at a fixed post-BMT time. This finding and thus it would be quite difficult to isolate the offending drug, if any. Cyclophosphamide, methotrexate and busulfan argues against the assumption of BAL normality in BMT patients without lung disease based on the findings from a have been identified as causes of lymphocytic alveolitis, and busulfan is also a cause of neutrophilic alveolitis. 16 In small group of patients. [4] [5] [6] As the smaller macrophages may be confused with lymthese iatrogenic lung diseases, BAL can show different cellular profiles, but none is specific. Therefore, BAL phocytes, could our high BAL lymphocyte percentages be due to an overestimate? Although theoretically possible, examination is not sufficient to ensure a diagnosis. All of our patients received cyclosporine for 6 months, but this there are several reasons against this possibility. (1) All the differential cell counts were carried out by the same drug has not been associated with alveolitis. Methotrexate, one of the drugs with a well established role in drugexperienced pathologist. This sort of misinterpretation would be unlikely to occur only in BMT BALs and not in induced pneumonitis, was administered for a very short time and at a very low dose, which makes any relation with BALs from healthy subjects. (2) The range of BAL lymphocyte percentages in BMT patients was wide, which the abnormal alveolar cellular composition unlikely. We found no correlation between several patient characwould imply a large variability in misinterpretation from sample to sample. (3) Finally, an increased number of lymteristics and some transplant events, including TBI, acute GVHD, asymptomatic CMV isolation in BAL, peripheral phocytes in BAL from marrow transplant patients without pneumonia has been confirmed in a previous study. 2 blood white cell differential count in BAL, with the type of cells recovered in the lavage fluid as previously Although there are several explanations for an increased number of BAL neutrophils, none accounts for the neutroreported. 1,2,3,17 We only observed a weak relationship with leucocyte engraftment: the later the engraftment occurred philic alveolitis found in our BMT patients. 7 (1) Contamination with blood from bronchoscopy trauma (an unusual the more lymphocytes and the fewer macrophages in the BAL. In consequence, we could not find an explanation occurrence). This possibility can be easily excluded by examination of the cytocentrifuged BAL preparations. (2) for the different and variable cellular BAL composition in asymptomatic patients. In normal individuals, there is a corknown exactly (an approximate estimation appears on Table 5 ). The percentage of lymphocytes (approximately relation between BAL lymphocytes and peripheral blood lymphocytes. However, it has been shown that little or no 20%) seems higher than in healthy volunteers. Winston et al 23 studied seven allogeneic BMTs and found a wide range correlation exists between the pulmonary immune response and the number of peripheral blood lymphocytes in sysin the percentage of lymphocytes as well as a high mean of neutrophils, with one case containing up to 10%. temic diseases affecting the lung. This suggests that the immune response is compartmentalised in several disRecent evidence has shown that CMV infection of granulocytes in vivo is productive. 24 Thus, it is likely that durorders 7, 18, 19 which could explain the lack of relationship between peripheral blood and BAL lymphocyte counts in ing an active infection, productive infection of PMN could substantially contribute to the dissemination of viruses as BMT patients whose immunologic systems differ from those of healthy individuals, as previously described. 3, 17 they migrate to the lung, gastrointestinal tract, liver and spleen. 24 The high incidence of neutrophil alveolitis found We do not know the clinical relevance of the alveolar neutrophilia found in asymptomatic BMT patients, in asymptomatic BMT patients may contribute to the increased incidence of CMV lung infection (54%) 9 and although there is some evidence to support the view that a proportion of patients with this finding or a certain level pneumonitis (15-30%) 25 in this population, due to the accumulation of a great mass of infected cells during an of alveolar neutrophilia could suffer pathological sequelae. Under these circumstances, small lung insults could be active infection. Although the CMV pneumonitis in these patients is probably an immunopathological condition 26 the amplified by a large pool of alveolar neutrophils with resulting serious lung damage. Alveolar neutrophilia has presence of a high number of infected cells in the alveoli could facilitate the initiation of this pathologic process. The been associated with the development of alveolar haemorrhage in BMT patients 20 and progressive functional finding of an 86% neutrophilic alveolitis in the BAL from asymptomatic patients with CMV supports this view. derangement. 7, 21 Whether or not this association (neutrophil alveolitis and deterioration of PFT) occurs in asymptomatic Alveolar neutrophilia could be a risk factor for CMV lung infection and disease. It would be interesting to know if BMT patients is unknown. None the less, as previously observed, PMN accumulation in the alveoli, by itself, probautologous transplants have the same asymptomatic neutrophil alveolitis in order to understand the origin of this findably does not induce alveolar damage. Bacterial pneumonia associated with high alveolar PMN counts generally clears ing better.
BMT patients Healthy volunteers
In conclusion, the BAL cellular composition in allowithout major parenchymal sequelae. Thus, along with the presence of neutrophils in the alveoli, the influence of sevgeneic BMT patients without clinical evidence of lung complications is clearly different from that of normal healeral environmental factors could account for the apparent paradox: high PMN numbers can sometimes be observed thy volunteers, the principal characteristics being a marked increase in alveolar neutrophils (in 82% of the patients) and in alveoli without major lesions while in other conditions a marginal increase of PMNs in the respiratory tract can be an increase in lymphocytes. A greater variation in cellular populations was found without an evident cause. The numassociated with major damage and irreversible architectural lung changes. 22 ber of cells per ml of fluid recovered appears similar to that found in healthy volunteers. The high frequency of neutroTotal lavage cell counts were performed in 44 BALs from 27 patients. No differences from healthy controls were phil alveolitis could be one of the reasons for the particular incidence of CMV lung infection and pneumonitis in allofound. Since the number of control BALs was low, results of the comparisons should be taken cautiously. The only geneic BMT patients. Due to the difference and variability of BAL cellular composition in asymptomatic patients great significant difference observed in BAL cellularity was that related to smoking history. BALs from smokers yielded caution should be taken when interpreting data in pathologic conditions. In order to avoid drawing wrong conmore cells than those from non-smokers, resembling the findings in healthy volunteers.
clusions, BAL composition of BMT patients with lung complications should be compared with that from a control No studies on the cellular BAL composition of BMT patients without lung disorders have been published to date, group of BMT patients without lung complications instead of with that from healthy volunteers. and only a few articles have included a small group of asymptomatic BMT patients as a comparative or control group 1,2,4-6,23 (summary in Table 5 ). In a study by Bowden et al 2 a significant increase in the percentage of lympho
